DK3324938T3 - Topikale formuleringer og behandlinger - Google Patents

Topikale formuleringer og behandlinger Download PDF

Info

Publication number
DK3324938T3
DK3324938T3 DK16828382.8T DK16828382T DK3324938T3 DK 3324938 T3 DK3324938 T3 DK 3324938T3 DK 16828382 T DK16828382 T DK 16828382T DK 3324938 T3 DK3324938 T3 DK 3324938T3
Authority
DK
Denmark
Prior art keywords
treatments
topical formulations
topical
formulations
Prior art date
Application number
DK16828382.8T
Other languages
English (en)
Inventor
Hemant H Alur
James A H Harwick
Original Assignee
Trilogic Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trilogic Pharma Llc filed Critical Trilogic Pharma Llc
Application granted granted Critical
Publication of DK3324938T3 publication Critical patent/DK3324938T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK16828382.8T 2015-07-20 2016-07-18 Topikale formuleringer og behandlinger DK3324938T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562194518P 2015-07-20 2015-07-20
PCT/US2016/042843 WO2017015232A1 (en) 2015-07-20 2016-07-18 Topical formulations and treatments

Publications (1)

Publication Number Publication Date
DK3324938T3 true DK3324938T3 (da) 2021-09-27

Family

ID=57835134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16828382.8T DK3324938T3 (da) 2015-07-20 2016-07-18 Topikale formuleringer og behandlinger

Country Status (11)

Country Link
US (2) US11129896B2 (da)
EP (1) EP3324938B1 (da)
CA (2) CA3209380A1 (da)
DK (1) DK3324938T3 (da)
ES (1) ES2891754T3 (da)
HU (1) HUE056401T2 (da)
LT (1) LT3324938T (da)
MX (2) MX2018000800A (da)
PL (1) PL3324938T3 (da)
PT (1) PT3324938T (da)
WO (1) WO2017015232A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180104166A (ko) 2016-02-09 2018-09-19 브라코 스위스 에스.에이. 셀렉틴 표적화를 위한 재조합 키메라 단백질
CA3227291A1 (en) * 2021-07-26 2023-02-02 David Friend Compositions for use in the treatment of bacterial vaginosis
WO2023009461A2 (en) * 2021-07-26 2023-02-02 Dare Bioscience, Inc. Compositions and techniques for vaginal insertion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE306274T1 (de) 1997-11-24 2005-10-15 Zhongming Zeng Verwendung von dextrin, stärke oder glykogen zur behandlung von bakterieller vaginosis
US20040167223A1 (en) 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1311873C (zh) 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
CN101557802B (zh) * 2007-12-03 2013-10-30 特里逻辑药业有限责任公司 自凝固的可生物蚀解的屏障植入物
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010047831A1 (en) 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
CN102525884A (zh) 2010-12-19 2012-07-04 复旦大学 一种用于阴道给药的温敏原位凝胶制剂

Also Published As

Publication number Publication date
HUE056401T2 (hu) 2022-02-28
PL3324938T3 (pl) 2022-01-10
US11129896B2 (en) 2021-09-28
EP3324938A1 (en) 2018-05-30
EP3324938A4 (en) 2019-03-13
US20180207275A1 (en) 2018-07-26
WO2017015232A1 (en) 2017-01-26
MX2022001736A (es) 2022-03-11
EP3324938B1 (en) 2021-09-01
CA3209380A1 (en) 2017-01-26
ES2891754T3 (es) 2022-01-31
MX2018000800A (es) 2018-08-16
LT3324938T (lt) 2021-11-25
CA2993012C (en) 2023-10-03
PT3324938T (pt) 2021-09-21
US20220040306A1 (en) 2022-02-10
CA2993012A1 (en) 2017-01-26

Similar Documents

Publication Publication Date Title
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3258942T3 (da) Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol
DK3389658T3 (da) Glycosidasehæmmere og anvendelser deraf
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK3452463T3 (da) Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf
DK3142637T3 (da) Keratin treatment formulations and methods
DK3319428T3 (da) Herbicid sammensætning omfattende cinmethylin og imazamox
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3192869T3 (da) Isoleret oligonukleotid og anvendelse deraf i nukleinsyresekvensering
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3049056T4 (da) Topisk antisvampesammensætning og fremgangsmåder til behandling
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3395801T3 (da) Arylazolforbindelse og skadedyrsbekæmpelsesmiddel
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3256598T3 (da) Svampestammer og anvendelsesfremgangsmåder
DK3265641T3 (da) Stigørenhed og fremgangsmåde
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3280423T3 (da) Synergistisk glycocalyx behandlingssammensætninger og fremgangsmåder
BR112016027379A2 (pt) formulações tópicas e seus usos
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
IL268583A (en) Preparations and methods for use on the skin
DK3386956T3 (da) Fumagillolderivater og polymorfer deraf